The heritability of antinociception: Common pharmacogenetic mediation of five neurochemically distinct analgesics

Journal of Pharmacology and Experimental Therapeutics

Volumn 304, Issue 2, 2003, Pages 547-559

  Wilson, Sonya G ^a   Smith, Shad B ^b   Chesler, Elissa J ^a   Melton, Kimberly A ^a   Haas, Jeremiah J ^a   Mitton, Bryan ^a   Strasburg, Kate ^b   Hubert, Lawrence ^a   Rodriguez Zas, Sandra L ^a   Mogil, Jeffrey S ^a,b  

^a UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

^b MCGILL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

2,3 DIHYDRO 5 METHYL 3 (MORPHOLINOMETHYL) 6 (1 NAPHTHOYL)PYRROLO[1,2,3 DE][1,4]BENZOXAZINE; 3,4 DICHLORO N METHYL N [2 (1 PYRROLIDINYL)CYCLOHEXYL]BENZENEACETAMIDE; ADRENERGIC RECEPTOR STIMULATING AGENT; ANALGESIC AGENT; CANNABINOID RECEPTOR AGONIST; CLONIDINE; EPIBATIDINE; KAPPA OPIATE RECEPTOR AGONIST; MU OPIATE RECEPTOR AGONIST; NICOTINIC AGENT;

ANIMAL EXPERIMENT; ANTINOCICEPTION; ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DRUG ACTIVITY; DRUG POTENCY; DRUG SENSITIVITY; FEMALE; HERITABILITY; MALE; MOUSE STRAIN; NOCICEPTION; NONHUMAN; PHARMACOGENETICS; PRIORITY JOURNAL;

ANALGESICS; ANIMALS; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; MALE; MICE; MICE, INBRED A; MICE, INBRED AKR; MICE, INBRED BALB C; MICE, INBRED C3H; MICE, INBRED C57BL; MICE, INBRED CBA; MICE, INBRED DBA; PAIN; PAIN MEASUREMENT; PHARMACOGENETICS; SEX CHARACTERISTICS; SPECIES SPECIFICITY;

EID: 0037308005     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: 10.1124/jpet.102.041889     Document Type: Article

References (80)

1. Aceto MD, Scates SM, Ji Z, and Bowman ER (1993) Nicotine's opioid and anti-opioid interactions: proposed role in smoking behavior. Eur J Pharmacol 248:333-335.
2. Ameri A (1999) The effects of cannabinoids on the brain. Prog Neurobiol 58:315-348.
3. Barrett AC, Cook CD, Terner JM, Roach EL, Syvanthong C, and Picker MJ (2002) Sex and rat strain determine sensitivity to κ opioid-induced antinociception. Psychopharmacology 160:170-181.
4. Basbaum AI and Fields HL (1984) Endogenous pain control systems: brainstem spinal pathways and endorphin circuitry. Annu Rev Neurosci 7:309-338.
5. Belknap JK and Crabbe JC (1992) Chromosome mapping of gene loci affecting morphine and amphetamine responses in BXD recombinant inbred mice. Ann NY Acad Sci 654:311-323.
6. Belknap JK, Danielson PW, Laursen SE, and Noordewier B (1987) Selective breeding for levorphanol-induced antinociception on the hot-plate assay: commonalities in mechanism of action with morphine, pentazocine, ethylketocyclazocine, U-50488H and clonidine in mice. J Pharmacol Exp Ther 241:477-481.
7. Belknap JK, Haltli NR, Goebel DM, and Lamé M (1983) Selective breeding for high and low levels of opiate-induced analgesia in mice. Behav Genet 13:383-396.
8. Belknap JK, Mogil JS, Helms ML, Richards SP, O'Toole LA, Bergeson SE, and Buck KJ (1995) Localization to proximal Chromosome 10 of a locus influencing morphine-induced analgesia in crosses derived from C57BL/6 and DBA/2 mouse strains. Life Sci 57:PL117-P124.
9. Belknap JK, Noordewier B, and Lamé M (1989) Genetic dissociation of multiple morphine effects among C57BL/6J, DBA/2J and C3H/HeJ inbred mouse strains. Physiol Behav 46:69-74.
10. Ben-Bassat J, Peretz E, and Sulman FG (1959) Analgesimetry and ranking of analgesic drugs by the receptacle method. Arch Int Pharmacodyn Ther 122:434-447.
11. Benjamini Y and Hochberg Y (1995) Controlling the False Discovery Rate: a practical and powerful approach to multiple testing J R Stat Soc Ser B 57:289-300.
12. Bergeson SE, Helms ML, O'Toole LA, Jarvis MW, Hain HS, Mogil JS, and Belknap JK (2001) Quantitative trait loci influencing morphine antinociception in four mapping populations. Mamm Genome 12:546-553.
13. Bonhaus DW, Bley KR, Broka CA, Fontana DJ, Leung E, Lewis R, Shieh A, and Wong EH (1995) Characterization of the electrophysiological, biochemical and behavioral actions of epibatidine. J Pharmacol Exp Ther 272:1199-1203.
14. Buchsbaum MS, Davis GC, and Bunney WE Jr (1977) Naloxone alters pain perception and somatosensory evoked potentials in normal subjects. Nature (Lond) 270:620-622.
15. Connor M and Christie MJ (1999) Opioid receptor signalling mechanisms. Clin Exp Pharm Physiol 26:493-499.
16. Crabbe JC, Phillips TJ, Kosobud A, and Belknap JK (1990) Estimation of genetic correlation: interpretation of experiments using selectively bred and inbred animals. Alcohol Clin Exp Res 14:141-151.
17. Craft RM (2002) Sex differences in opioid analgesia: "from mouse to man". J Clin Pain, in press.
18. Craft RM, Tseng AH, McNiel DM, Furness MS, and Rice KC (2001) Receptor-selective antagonism of opioid antinociception in female versus male rats. Behav Pharmacol 12:591-602.
19. Damaj MI, Creasy KR, Grove AD, Rosecrans JA, and Martin BR (1994) Pharmacological effects of epibatidine optical enantiomers. Brain Res 664:34-40.
20. Davenport KE, Houdi AA, and Van Loon GR (1990) Nicotine protects against muopioid receptor antagonism by beta-funaltrexamine: evidence for nicotine-induced release of endogenous opioids in brain. Neurosci Lett 113:40-46.
21. Decker MW, Bannon AW, Buckley MJ, Kim DJ, Holladay MW, Ryther KB, Lin NH, Wasicak JT, Williams M, and Arneric SP (1998) Antinociceptive effects of the novel neuronal nicotinic acetylcholine receptor agonist, ABT-594, in mice. Eur J Pharmacol 346:23-33.
22. Dirig DM and Yaksh TL (1995) Differential right shifts in the dose-response curve for intrathecal morphine and sufentanil as a function of stimulus intensity. Pain 62:321-328.
23. Dubuisson D and Dennis SG (1977) The formalin test: a quantitative study of the analgesic effects of morphine, meperidine and brain stem stimulation in rats and cats. Pain 4:161-174.
24. Elmer GI, Pieper JO, Negus SS, and Woods JH (1997) Genetic variance in nociception and its relationship to the potency of morphine-induced analgesia in thermal and chemical tests. Pain 75:129-140.
25. El-Sobky A, Dostrovsky JO, and Wall PD (1976) Lack of effect of naloxone on pain perception in humans. Nature (Lond) 263:783-784.
26. Falconer DS and Mackay TFC (1996) Introduction to Quantitative Genetics. Longman, Essex, UK.
27. Fernandes M and Hill R (1974) Morphine-cannabinoid interactions in rats and mice. Naunyn-Schmiedeberg's Arch Pharmacol 282:R19.
28. Flores CM and Hargreaves KM (1999) Neuronal nicotinic receptors: new targets in the treatment of pain, in Neuronal Nicotinic Receptors: Pharmacology and Therapeutic Opportunities (Arneric SP and Brioni JD eds) pp 359-377, Wiley-Liss, New York.
29. Flores CM, Wilson SG, and Mogil JS (1999) Pharmacogenetic variability in neuronal nicotinic receptor-mediated antinociception. Pharmacogenetics 9:619-625.
30. Hain HS, Belknap JK, and Mogil JS (1999) Pharmacogenetic evidence for the involvement of 5-hydroxytryptamine (serotonin)-1B receptors in the mediation of morphine antinociceptive sensitivity. J Pharmacol Exp Ther 291:444-449.
31. Jaffe JH and Martin WR (1990) Opioid analgesics and antagonists, in Goodman and Gilman's The Pharmacological Basis of Therapeutics, 8th ed (Gilman AG, Rall TW, Nies AS, and Taylor P eds) pp 485-521, Pergamon Press, New York.
32. Janssen PAJ, Niemegeers CJE, and Dony JGH (1963) The inhibitory effect of fentanyl and other morphine-like analgesics on the warm water induced tail withdrawal reflex. Arzneim-Forsch 13:502-507.
33. Kest B, Wilson SG, and Mogil JS (1999) Sex differences in supraspinal morphine analgesia are dependent on genotype. J Pharmacol Exp Ther 289:1370-1375.
34. Khan IM, Buerkle H, Taylor P, and Yaksh TL (1998) Nociceptive and antinociceptive responses to intrathecally administered nicotinic agonists. Neuropharmacology 37:1515-1525.
35. Kieffer BL (1999) Opioids: first lessons from knockout mice. Trends Pharmacol Sci 20:19-26.
36. Kunos G, Mosqueda-Garcia R, Mastrianni JA, and Abbott FV (1987) Endorphinergic mechanism in the central cardiovascular and analgesic effects of clonidine. Can J Physiol Pharmacol 65:1624-1632.
37. Lariviere WR, Chesler EJ, and Mogil JS (2001) Transgenic studies of pain and analgesia: mutation or background phenotype? J Pharmacol Exp Ther 297:467-473.
38. Lariviere WR, Wilson SG, Laughlin TM, Kokayeff A, West EE, Adhikari SM, Wan Y, and Mogil JS (2002) Heritability of nociception. III. Genetic relationships among commonly used assays of nociception and hypersensitivity. Pain 97:75-86.
39. Lee DH, Chung K, and Chung JM (1997) Strain differences in adrenergic sensitivity of neuropathic pain behaviors in an experimental rat model. Neuroreport 8:3453-3456.
40. Limbird LE (1988) Receptors linked to inhibition of adenylate cyclase: additional signaling mechanisms. FASEB J 2:2686-2695.
41. Liston EH, Simpson JH, Jarvik LF, and Guthrie D (1981) Morphine and experimental pain in identical twins. Prog Clin Biol Res 69:105-116.
42. Lynch M and Walsh B (1998) Genetics and Analysis of Quantitative Traits. Sinauer, Sunderland, MA.
43. MacPherson RD (2000) The pharmacological basis of contemporary pain management. Pharmacol Ther 88:163-185.
44. Maier C, Hildebrandt J, Klinger R, Henrich-Eberl C, Lindena G, and MONTAS Study Group (2002) Morphine responsiveness, efficacy and tolerability in patients with chronic non-tumor associated pain - results of a double-blind placebo-controlled trial (MONTAS). Pain 97:223-233.
45. Marek P, Mogil JS, Belknap JK, Sadowski B, and Liebeskind JC (1993) Levorphanol and swim stress-induced analgesia in selectively bred mice: evidence for genetic commonalities. Brain Res 608:353-357.
46. Martin BR and Lichtman AH (1998) Cannabinoid transmission and pain perception. Neurobiol Dis 5:447-461.
47. Mason DJ Jr, Lowe J, and Welch SP (1999) Cannabinoid modulation of dynorphin A: correlation to cannabinoid-induced antinociception. Eur J Pharmacol 378:237-248.
48. Millan MJ (1990) κ-Opioid receptors and analgesia. Trends Pharmacol Sci 11:70-76.
49. Mogil JS (1999) The genetic mediation of individual differences in sensitivity to pain and its inhibition. Proc Natl Acad Sci USA 96:7744-7751.
50. Mogil JS (2000) Genetic correlations among common nociceptive assays in the mouse: how many types of pain?, in Proceedings of the 9th World Congress on Pain; 1999 Aug 22-27 (Devor M, Rowbotham MC, and Wiesenfeld-Hallin Z eds) pp 455-470, IASP Press, Seattle.
51. Mogil JS, Chesler EJ, Wilson SG, Juraska JM, and Sternberg WF (2000) Sex differences in thermal nociception and morphine antinociception in rodents depend on genotype. Neurosci Biobehav Rev 24:375-389.
52. Mogil JS, Kest B, Sadowski B, and Belknap JK (1996a) Differential genetic mediation of sensitivity to morphine in genetic models of opiate antinociception: influence of nociceptive assay. J Pharmacol Exp Ther 276:532-544.
53. Mogil JS, Lichtensteiger CA, and Wilson SG (1998) The effect of genotype on sensitivity to inflammatory nociception: characterization of resistant (A/J) and sensitive (C57BL/6) inbred mouse strains. Pain 76:115-125.
54. Mogil JS, Marek P, Flodman P, Spence MA, Sternberg WF, Kest B, Sadowski B, and Liebeskind JC (1995) One or two genetic loci mediate high opiate analgesia in selectively bred mice. Pain 60:125-135.
55. Mogil JS, Sternberg WF, Marek P, Sadowski B, Belknap JK, and Liebeskind JC (1996b) The genetics of pain and pain inhibition. Proc Natl Acad Sci USA 93:3048-3055.
56. Mogil JS, Wilson SG, Bon K, Lee SE, Chung K, Raber P, Pieper JO, Hain HS, Belknap JK, Hubert L, et al. (1999a) Heritability of nociception. I. Responses of eleven inbred mouse strains on twelve measures of nociception. Pain 80:67-82.
57. Mogil JS, Wilson SG, Bon K, Lee SE, Chung K, Raber P, Pieper JO, Hain HS, Belknap JK, Hubert L, et al. (1999b) Heritability of nociception. II. "Types" of nociception revealed by genetic correlation analysis. Pain 80:83-93.
58. Molinero MT and Del Rio J (1987) Substance P, nicotinic acetylcholine receptors and antinociception in the rat. Neuropharmacology 26:1715-1720.
59. Onaivi ES, Chakrabarti A, Gwebu ET, and Chaudhuri G (1996) Neurobehavioral effects of D9-THC and cannabinoid (CB1) receptor gene expression in mice. Behav Brain Res 72:115-125.
60. Panocka I, Marek P, and Sadowski B (1986) Inheritance of stress-induced analgesia in mice. Selective breeding study. Brain Res 397:152-155.
61. Pasternak GW (1993) Pharmacological mechanisms of opioid analgesics. Clin Neuropharmacol 16:1-18.
62. Pick CG, Cheng J, Paul D, and Pasternak GW (1991) Genetic influences in opioid analgesic sensitivity in mice. Brain Res 566:295-298.
63. Rady JJ, Elmer GI, and Fujimoto JM (1998) Opioid receptor selectivity of heroin given intracerebroventricularly differs in six strains of inbred mice. J Pharmacol Exp Ther 288:438-445.
64. Reche I, Fuentes JA, and Ruiz-Gayo M (1996) A role for central cannabinoid and opioid systems in peripheral delta 9-tetrahydrocannabinol-induced analgesia in mice. Eur J Pharmacol 301:75-81.
65. Richardson JD, Aanonsen L, and Hargreaves KM (1997) SR 14176A, a cannabinoid receptor antagonist, produces hyperalgesia in untreated mice. Eur J Pharmacol 319:R3-R4.
66. Saddi G-M and Abbott FV (2000) The formalin test in the mouse: a parametric analysis of scoring properties. Pain 89:53-63.
67. Saeki S and Yaksh TL (1992) Suppression by spinal alpha-2 agonists of motor and autonomic responses evoked by low- and high-intensity thermal stimuli. J Pharmacol Exp Ther 260:795-802.
68. Seale TW, Nael R, and Basmadjian G (1996) Inherited, selective hyporesponsiveness to the analgesic action of nicotine in mice. Neuroreport 8:191-195.
69. Sierralta F, Naquira D, Pinardi G, and Miranda HF (1996) alpha-Adrenoceptor and opioid receptor modulation of clonidine-induced antinociception. Br J Pharmacol 119:551-554.
70. Spaulding TC, Fielding S, Venafro JJ, and Lal H (1979) Antinociceptive activity of clonidine and its potentiation of morphine analgesia. Eur J Pharmacol 58:19-25.
71. Suh HW, Song DK, Choi SR, Chung KM, and Kim YH (1996) Nicotine enhances morphine- and beta-endorphin-induced antinociception at the supraspinal level in the mouse. Neuropeptides 30:479-484.
72. Swiger LA, Harvey WR, Everson DO, and Gregory KE (1964) The variance of intraclass correlation involving groups with one observation. Biometrics 20:818.
73. Tallarida RJ and Murray RB (1981) Manual of Pharmacologic Calculation, Springer-Verlag, New York.
74. Tchakarov L, Abbott FV, Ramirez-Gonzalez MD, and Kunos G (1985) Naloxone reverses the antinociceptive action of clonidine in spontaneously hypertensive rats. Brain Res 328:33-40.
75. Tejwani GA and Rattan AK (2000) Antagonism of antinociception produced by intrathecal clonidine by ketorolac in the rat: the role of the opioid system. Anesth Analg 90:1152-1156.
76. Wilcox GL, Carlsson K-H, Joehim A, and Jurna I (1987) Mutual potentiation of antinociceptive effects of morphine and clonidine in rat spinal cord. Brain Res 405:84-93.
77. Wilson SG, Melton KA, Wickesburg RE, and Mogil JS (1999) Strain-dependent antinociception from the cannabinoid receptor agonist, WIN 55,212-2. Soc Neurosci Abstr 25:924.
78. Yaksh TL (1999) Spinal systems and pain processing: development of novel analgesic drugs with mechanistically defined models. Trends Pharmacol Sci 20:329-337.
79. Yamazaki A and Kaneto H (1985) Single dose tolerance to the analgesic effect of clonidine and cross-tolerance between morphine and clonidine. Jpn J Pharmacol 39:461-465.
80. Zarrindast MR, Nami AB, and Farzin D (1996) Nicotine potentiates morphine antinociception: a possible cholinergic mechanism. Eur Neuropsychopharmacol 6:127-133.